Kanabo Group (LON:KNB) Sets New 12-Month Low – Should You Sell?

Kanabo Group Plc (LON:KNB)’s share price reached a new 52-week low on Monday . The stock traded as low as GBX 0.90 ($0.01) and last traded at GBX 0.91 ($0.01), with a volume of 342236 shares changing hands. The stock had previously closed at GBX 0.92 ($0.01).

Kanabo Group Trading Down 9.0 %

The company’s 50 day simple moving average is GBX 1.13 and its 200 day simple moving average is GBX 1.34. The firm has a market cap of £5.76 million, a price-to-earnings ratio of -92.10 and a beta of 3.04. The company has a debt-to-equity ratio of 3.49, a current ratio of 2.78 and a quick ratio of 24.36.

Insider Buying and Selling

In other news, insider Ian Mattioli purchased 150,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 27th. The stock was purchased at an average cost of GBX 1 ($0.01) per share, with a total value of £1,500 ($1,930.25). Insiders own 37.01% of the company’s stock.

About Kanabo Group

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.